Reaction
Tongue Blistering reporting signals
As of the last recalculation, Tongue Blistering appears in 2,212 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is ASENAPINE MALEATE (PRR 35.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Asenapine Maleate | 32 | 35.2 | 35.4 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 83 | 33.6 | 33.7 |
| Sunitinib Malate | 59 | 14.5 | 14.5 |
| Sorafenib | 29 | 13.3 | 13.3 |
| Cabozantinib | 61 | 12.3 | 12.3 |
| Baricitinib | 12 | 11.8 | 11.8 |
| Nicotine Polacrilex | 41 | 10.3 | 10.3 |
| Drs. Clotrimazole | 11 | 9.0 | 9.0 |
| Family Wellness Clotrimazole | 11 | 9.0 | 9.0 |
| Clotrimazole Topical | 11 | 9.0 | 9.0 |
| Regorafenib | 11 | 9.0 | 9.0 |
| Clotrimazole | 11 | 8.5 | 8.5 |
| Lanreotide Acetate | 7 | 8.4 | 8.4 |
| Everolimus | 33 | 6.2 | 6.2 |
| Fulvestrant | 21 | 6.0 | 6.0 |
| Axitinib | 12 | 5.8 | 5.8 |
| Nicotine | 24 | 5.6 | 5.6 |
| Alpelisib | 5 | 5.4 | 5.4 |
| Varenicline Tartrate | 44 | 5.3 | 5.3 |
| Niraparib | 12 | 5.1 | 5.1 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 9 | 5.1 | 5.1 |
| Fremanezumab-Vfrm | 6 | 4.9 | 4.9 |
| Armodafinil | 11 | 4.9 | 4.9 |
| Ibuprofen Tablets, Coated | 22 | 4.9 | 4.9 |
| Rucaparib | 4 | 4.3 | 4.3 |
| Peginterferon Alfa-2A | 24 | 4.2 | 4.2 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 18 | 4.1 | 4.1 |
| Palbociclib | 39 | 3.9 | 3.9 |
| Lenvatinib | 12 | 3.5 | 3.5 |
| Sevelamer Carbonate | 4 | 3.3 | 3.3 |
| Nirmatrelvir And Ritonavir | 18 | 3.1 | 3.1 |
| Vemurafenib | 4 | 3.1 | 3.1 |
| Abemaciclib | 6 | 2.8 | 2.8 |
| Galcanezumab-Gnlm | 5 | 1.5 | 1.5 |
| Valbenazine | 3 | 1.1 | 1.1 |